Warehousing
AXXO is authorized to trade dangerous goods, narcotics, psychotropics, and precursors. Their shipments are temperature-controlled and comply with GMP and GDP guidelines.
Our Philosophy
AXXO understood it like no other firm in the health market, to transfer market chances through dynamic acting into success. Also the most important foreign subsidiaries are showing a continuous growth in the key segments which lies usually above the respective national markets.
With the strategy “AXXO – the Health Company” we concentrate on segments with extraordinary strong growth in the global health market. For years AXXO has already focused on four core segments: Generics (medicines which are offered after the expiration of their patents at the same quality but for significantly lower prices), Brand-Name Products for the health market, Similarity Products (brand-name copy products of well established substances) and Special Pharmaceuticals (like medicines for cancer therapy).
Our Philosophy
AXXO understood it like no other firm in the health market, to transfer market chances through dynamic acting into success. Also the most important foreign subsidiaries are showing a continuous growth in the key segments which lies usually above the respective national markets.
With the strategy “AXXO – the Health Company” we concentrate on segments with extraordinary strong growth in the global health market. For years AXXO has already focused on four core segments: Generics (medicines which are offered after the expiration of their patents at the same quality but for significantly lower prices), Brand-Name Products for the health market, Similarity Products (brand-name copy products of well established substances) and Special Pharmaceuticals (like medicines for cancer therapy).
About us
Who we are
AXXO is an internationally acting company in the pharmaceutical sector. We are present all over the world; in the CIS countries, various Latin American markets and MENA-region.
What we do
Our dynamic and highly motivated team is scrutinizing, developing, producing and distributing innovative pharmaceutical products. We are offering just-in-time delivery, customized product parameters as well as registration support.
Our Expertise
Our expertise consists of the development and registration of pharmaceutical products with special emphasis in fields of Biotechnology, Oncology as well as Generic Drugs.
1
2
3
4
5
6
7
1
AXXO Headquarter
2
Joint Venture in Uzbekistan
3
Biotech partner in Mexico
4
Headquarter AXXO-RUS
5
Joint Venture in Belarus
6
Manufacturer partner in China
7
Biotech partner in Argentina
Portfolio
Product categories
The product portfolio embraces finished dosage pharmaceuticals, active pharmaceutical ingredients, recombinant Human proteins (biotechnology) and medical devices.
WoundGel
The AXXO Woundgel is a plant based, non-allergenic hydrogel based on a unique microsphere technology. It contains PHMB incorporated into fully biodegradable starch microspheres, which are suspended in a gel matrix for optimal infection prevention and treatment. The gel delivers moisture to the wound, whilst maintaining enough absorption capacity for exudate, debris and bacteria. The AXXO Woundgel is a CE-certified medical device of class IIb.
Latest Events
Upcoming Events
Get in touch
(+49) 040 389194 0
pharma@axxo.de
OFFICE LOCATION:
Rödingsmarkt 20
20459 Hamburg
Germany
Get in touch
(+49) 040 389194 0
pharma@axxo.de
OFFICE LOCATION:
Rödingsmarkt 20
20459 Hamburg
Germany
